Menu
GeneBe

16-55566926-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_032330.3(CAPNS2):c.170C>G(p.Thr57Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T57I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

CAPNS2
NM_032330.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.00
Variant links:
Genes affected
CAPNS2 (HGNC:16371): (calpain small subunit 2) Enables calcium-dependent cysteine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
LPCAT2 (HGNC:26032): (lysophosphatidylcholine acyltransferase 2) This gene encodes a member of the lysophospholipid acyltransferase family. The encoded enzyme may function in two ways: to catalyze the biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from 1-O-alkyl-sn-glycero-3-phosphocholine, and to catalyze the synthesis of glycerophospholipid precursors from arachidonyl-CoA and lysophosphatidylcholine. The encoded protein may function in membrane biogenesis and production of platelet-activating factor in inflammatory cells. The enzyme may localize to the endoplasmic reticulum and the Golgi. [provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.040212125).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CAPNS2NM_032330.3 linkuse as main transcriptc.170C>G p.Thr57Ser missense_variant 1/1 ENST00000457326.3
LPCAT2NM_017839.5 linkuse as main transcriptc.1216-7705C>G intron_variant ENST00000262134.10
LPCAT2XM_011523169.4 linkuse as main transcriptc.406-7705C>G intron_variant
LPCAT2XM_047434277.1 linkuse as main transcriptc.1048-7705C>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CAPNS2ENST00000457326.3 linkuse as main transcriptc.170C>G p.Thr57Ser missense_variant 1/1 NM_032330.3 P1
LPCAT2ENST00000262134.10 linkuse as main transcriptc.1216-7705C>G intron_variant 1 NM_017839.5 P1Q7L5N7-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2023The c.170C>G (p.T57S) alteration is located in exon 1 (coding exon 1) of the CAPNS2 gene. This alteration results from a C to G substitution at nucleotide position 170, causing the threonine (T) at amino acid position 57 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.52
Cadd
Benign
11
Dann
Benign
0.94
DEOGEN2
Benign
0.0030
T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.023
T
M_CAP
Benign
0.0085
T
MetaRNN
Benign
0.040
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
1.0
D;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.23
N
REVEL
Benign
0.034
Sift
Benign
0.38
T
Sift4G
Benign
0.35
T
Polyphen
0.011
B
Vest4
0.062
MutPred
0.27
Gain of disorder (P = 0.0638);
MVP
0.35
MPC
0.12
ClinPred
0.13
T
GERP RS
5.7
Varity_R
0.081
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr16-55600838; API